Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

PETS vs TDOC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
PETS
PetMed Express, Inc.

Medical - Pharmaceuticals

HealthcareNASDAQ • US
Market Cap$48M
5Y Perf.-93.7%
TDOC
Teladoc Health, Inc.

Medical - Healthcare Information Services

HealthcareNYSE • US
Market Cap$1.26B
5Y Perf.-95.8%

PETS vs TDOC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
PETS logoPETS
TDOC logoTDOC
IndustryMedical - PharmaceuticalsMedical - Healthcare Information Services
Market Cap$48M$1.26B
Revenue (TTM)$195M$2.51B
Net Income (TTM)$-55M$-171M
Gross Margin29.9%65.6%
Operating Margin-11.1%-7.6%
Total Debt$996K$1.04B
Cash & Equiv.$55M$781M

PETS vs TDOCLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

PETS
TDOC
StockMay 20May 26Return
PetMed Express, Inc. (PETS)1006.3-93.7%
Teladoc Health, Inc. (TDOC)1004.2-95.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: PETS vs TDOC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: TDOC leads in 4 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. PetMed Express, Inc. is the stronger pick specifically for capital preservation and lower volatility and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
PETS
PetMed Express, Inc.
The Income Pick

PETS is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • Dividend streak 0 yrs, beta 1.25, yield 0.4%
  • Lower volatility, beta 1.25, Low D/E 1.2%, current ratio 1.26x
  • Beta 1.25, yield 0.4%, current ratio 1.26x
Best for: income & stability and sleep-well-at-night
TDOC
Teladoc Health, Inc.
The Growth Play

TDOC carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth -1.5%, EPS growth 80.6%, 3Y rev CAGR 1.7%
  • -41.1% 10Y total return vs PETS's -47.8%
  • -1.5% revenue growth vs PETS's -17.2%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthTDOC logoTDOC-1.5% revenue growth vs PETS's -17.2%
Quality / MarginsTDOC logoTDOC-6.8% margin vs PETS's -28.2%
Stability / SafetyPETS logoPETSBeta 1.25 vs TDOC's 1.91, lower leverage
DividendsPETS logoPETS0.4% yield; the other pay no meaningful dividend
Momentum (1Y)TDOC logoTDOC+1.5% vs PETS's -36.5%
Efficiency (ROA)TDOC logoTDOC-5.9% ROA vs PETS's -54.9%, ROIC -11.5% vs -3.1%

PETS vs TDOC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

PETSPetMed Express, Inc.

Segment breakdown not available.

TDOCTeladoc Health, Inc.
FY 2025
Other
100.0%$438M

PETS vs TDOC — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLPETSLAGGINGTDOC

Income & Cash Flow (Last 12 Months)

TDOC leads this category, winning 6 of 6 comparable metrics.

TDOC is the larger business by revenue, generating $2.5B annually — 12.9x PETS's $195M. TDOC is the more profitable business, keeping -6.8% of every revenue dollar as net income compared to PETS's -28.2%. On growth, TDOC holds the edge at -2.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricPETS logoPETSPetMed Express, I…TDOC logoTDOCTeladoc Health, I…
RevenueTrailing 12 months$195M$2.5B
EBITDAEarnings before interest/tax-$14M$42M
Net IncomeAfter-tax profit-$55M-$171M
Free Cash FlowCash after capex-$34M$251M
Gross MarginGross profit ÷ Revenue+29.9%+65.6%
Operating MarginEBIT ÷ Revenue-11.1%-7.6%
Net MarginNet income ÷ Revenue-28.2%-6.8%
FCF MarginFCF ÷ Revenue-17.4%+10.0%
Rev. Growth (YoY)Latest quarter vs prior year-25.5%-2.5%
EPS Growth (YoY)Latest quarter vs prior year-4.7%+32.1%
TDOC leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

PETS leads this category, winning 4 of 4 comparable metrics.
MetricPETS logoPETSPetMed Express, I…TDOC logoTDOCTeladoc Health, I…
Market CapShares × price$48M$1.3B
Enterprise ValueMkt cap + debt − cash-$5M$1.5B
Trailing P/EPrice ÷ TTM EPS-7.67x-6.11x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple-0.98x15.13x
Price / SalesMarket cap ÷ Revenue0.21x0.50x
Price / BookPrice ÷ Book value/share0.56x0.89x
Price / FCFMarket cap ÷ FCF4.40x
PETS leads this category, winning 4 of 4 comparable metrics.

Profitability & Efficiency

PETS leads this category, winning 5 of 9 comparable metrics.

TDOC delivers a -12.4% return on equity — every $100 of shareholder capital generates $-12 in annual profit, vs $-128 for PETS. PETS carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to TDOC's 0.75x. On the Piotroski fundamental quality scale (0–9), TDOC scores 6/9 vs PETS's 5/9, reflecting solid financial health.

MetricPETS logoPETSPetMed Express, I…TDOC logoTDOCTeladoc Health, I…
ROE (TTM)Return on equity-127.8%-12.4%
ROA (TTM)Return on assets-54.9%-5.9%
ROICReturn on invested capital-3.1%-11.5%
ROCEReturn on capital employed-1.7%-10.0%
Piotroski ScoreFundamental quality 0–956
Debt / EquityFinancial leverage0.01x0.75x
Net DebtTotal debt minus cash-$54M$259M
Cash & Equiv.Liquid assets$55M$781M
Total DebtShort + long-term debt$996,000$1.0B
Interest CoverageEBIT ÷ Interest expense-73.26x-8.76x
PETS leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

TDOC leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in PETS five years ago would be worth $1,792 today (with dividends reinvested), compared to $461 for TDOC. Over the past 12 months, TDOC leads with a +1.5% total return vs PETS's -36.5%. The 3-year compound annual growth rate (CAGR) favors TDOC at -35.6% vs PETS's -42.0% — a key indicator of consistent wealth creation.

MetricPETS logoPETSPetMed Express, I…TDOC logoTDOCTeladoc Health, I…
YTD ReturnYear-to-date-30.3%-1.3%
1-Year ReturnPast 12 months-36.5%+1.5%
3-Year ReturnCumulative with dividends-80.5%-73.3%
5-Year ReturnCumulative with dividends-82.1%-95.4%
10-Year ReturnCumulative with dividends-47.8%-41.1%
CAGR (3Y)Annualised 3-year return-42.0%-35.6%
TDOC leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — PETS and TDOC each lead in 1 of 2 comparable metrics.

PETS is the less volatile stock with a 1.25 beta — it tends to amplify market swings less than TDOC's 1.91 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TDOC currently trades 71.2% from its 52-week high vs PETS's 53.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricPETS logoPETSPetMed Express, I…TDOC logoTDOCTeladoc Health, I…
Beta (5Y)Sensitivity to S&P 5001.21x1.89x
52-Week HighHighest price in past year$4.32$9.77
52-Week LowLowest price in past year$1.57$4.40
% of 52W HighCurrent price vs 52-week peak+53.2%+71.2%
RSI (14)Momentum oscillator 0–10047.774.1
Avg Volume (50D)Average daily shares traded81K5.5M
Evenly matched — PETS and TDOC each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

PETS is the only dividend payer here at 0.38% yield — a key consideration for income-focused portfolios.

MetricPETS logoPETSPetMed Express, I…TDOC logoTDOCTeladoc Health, I…
Analyst RatingConsensus buy/hold/sellHold
Price TargetConsensus 12-month target$7.58
# AnalystsCovering analysts42
Dividend YieldAnnual dividend ÷ price+0.4%
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS$0.01
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

TDOC leads in 2 of 6 categories (Income & Cash Flow, Total Returns). PETS leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.

Best OverallPetMed Express, Inc. (PETS)Leads 2 of 6 categories
Loading custom metrics...

PETS vs TDOC: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is PETS or TDOC a better buy right now?

For growth investors, Teladoc Health, Inc.

(TDOC) is the stronger pick with -1. 5% revenue growth year-over-year, versus -17. 2% for PetMed Express, Inc. (PETS). Analysts rate Teladoc Health, Inc. (TDOC) a "Hold" — based on 42 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — PETS or TDOC?

Over the past 5 years, PetMed Express, Inc.

(PETS) delivered a total return of -82. 1%, compared to -95. 4% for Teladoc Health, Inc. (TDOC). Over 10 years, the gap is even starker: TDOC returned -38. 7% versus PETS's -47. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — PETS or TDOC?

By beta (market sensitivity over 5 years), PetMed Express, Inc.

(PETS) is the lower-risk stock at 1. 21β versus Teladoc Health, Inc. 's 1. 89β — meaning TDOC is approximately 57% more volatile than PETS relative to the S&P 500. On balance sheet safety, PetMed Express, Inc. (PETS) carries a lower debt/equity ratio of 1% versus 75% for Teladoc Health, Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — PETS or TDOC?

By revenue growth (latest reported year), Teladoc Health, Inc.

(TDOC) is pulling ahead at -1. 5% versus -17. 2% for PetMed Express, Inc. (PETS). On earnings-per-share growth, the picture is similar: Teladoc Health, Inc. grew EPS 80. 6% year-over-year, compared to 18. 9% for PetMed Express, Inc.. Over a 3-year CAGR, TDOC leads at 1. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — PETS or TDOC?

PetMed Express, Inc.

(PETS) is the more profitable company, earning -2. 8% net margin versus -7. 9% for Teladoc Health, Inc. — meaning it keeps -2. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PETS leads at -0. 7% versus -10. 4% for TDOC. At the gross margin level — before operating expenses — TDOC leads at 69. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — PETS or TDOC?

In this comparison, PETS (0.

4% yield) pays a dividend. TDOC does not pay a meaningful dividend and should not be held primarily for income.

07

Is PETS or TDOC better for a retirement portfolio?

For long-horizon retirement investors, PetMed Express, Inc.

(PETS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 21)). Teladoc Health, Inc. (TDOC) carries a higher beta of 1. 89 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PETS: -47. 9%, TDOC: -38. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between PETS and TDOC?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

PETS

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 17%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

TDOC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 39%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform PETS and TDOC on the metrics below

Revenue Growth>
%
(PETS: -25.5% · TDOC: -2.5%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.